XBIOTECH INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
XBIOTECH INC. (XBIT) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $414.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-13
- XBIOTECH INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-12-31 was $29.00K.
- XBIOTECH INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $414.00K, a 22.85% increase from fiscal 2024.
- XBIOTECH INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $337.00K, a 243.88% increase from fiscal 2023.
- XBIOTECH INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $98.00K, a 5.38% increase from fiscal 2022.
- XBIOTECH INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $93.00K, a 66.07% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $414.00K 10-K · filed 2026-03-13 | |||
| 2024-12-31 | $337.00K 10-K · filed 2026-03-13 | |||
| 2023-12-31 | $98.00K 10-K · filed 2025-03-18 | $93.00K 10-K · filed 2024-03-15 | ||
| 2022-12-31 | $93.00K 10-K · filed 2025-03-18 | $63.00K 10-K · filed 2023-03-15 | ||
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $56.00K 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $27.00K 10-Q · filed 2021-11-09 | |||
| 2020-12-31 | $27.00K 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |